Safety and Efficacy of Berodual® Respimat® Compared to Berodual® MDI (Metered Dose Inhaler) in Asthma Patients

NCT02182479 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

631

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Berodual® via Respimat®, high dose
DRUG: Berodual® via Respimat®, low dose
DRUG: Berodual® via MDI, high dose
DRUG: Placebo Respimat®
DRUG: Placebo MDI

Sponsor

Boehringer Ingelheim